Effectiveness of chromium in atypical depression: a placebo-controlled trial
β Scribed by Jonathan R.T Davidson; Kurian Abraham; Kathryn M Connor; Malcolm N McLeod
- Book ID
- 119408960
- Publisher
- Elsevier Science
- Year
- 2003
- Tongue
- English
- Weight
- 42 KB
- Volume
- 53
- Category
- Article
- ISSN
- 0006-3223
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Ethics of placebo-controlled trials in depression Some believe that introducing a placebo control into an antidepressant drug trial means that ill patients are being unnecessarily deprived of treatment. As a result, many clinicians and ethical committees are opposed to the use of such trial met
A randomized double-blind placebotontrolled trial was carried out to assess the effectiveness, tolerance and unwanted effects of paroxetine in the treatment of depressive illness. Forty-one patients referred to a psychiatric unit in a general hospital were included in the study. Treatment lasted for
## Objectives: To determine the response of physically ill elderly depressed patients to treatment. ## Design: Acute geriatric medical inpatients with depression, randomly assigned to an 8-week double-blind placebo-controlled trial of fluoxetine. ## Main outcome measure: Response rate as define